The Chemo-Gut Trial: A double-blind randomized controlled trial investigating the effects of a multi-strain probiotic on gut microbiota, gastrointestinal symptoms, and psychosocial health in cancer survivors
The Chemo-Gut Trial: A double-blind randomized controlled trial investigating the effects of a multi-strain probiotic on gut microbiota, gastrointestinal symptoms, and psychosocial health in cancer survivors
化学肠道试验：一项双盲随机对照试验，研究多菌株益生菌对癌症幸存者肠道微生物群、胃肠道症状和心理社会健康的影响
批准号：
472129
负责人：
Deleemans Julie
金额：
$9.83万
依托单位：
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-10-01 至 2025-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background: For select cancers (e.g. leukemia, breast) 5-year survival rates range from 61 - 89% but many survivors will experience chronic symptoms after treatment ends. Our previous work shows that 52% of survivors experience moderate to severe gastroin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
